Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:35 PM
Ignite Modification Date:
2025-12-24 @ 6:35 PM
NCT ID:
NCT00577057
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven nasopharyngeal carcinoma
* Non-keratinizing or undifferentiated type Stage III-IVB (by AJCC/UICC 6th edition)
* Essential staging investigations: CT or MRI of nasopharyngeal region Chest x-ray (or CT thorax)
* Liver function test, alkaline phosphatase Liver and bone scan if alkaline phosphatase exceeds the institutional upper limit of normal, or if clinically indicated.
* Liver scan if SGOT exceeds the institutional upper limit of normal
* Adequate marrow: WBC \> 4 and platelet \> 100
* Adequate renal function: creatinine clearance \> 60 ml/min.
* Satisfactory performance status: \> 2 by ECOG System.
Exclusion Criteria:
* WHO Type I squamous cell carcinoma or adenocarcinoma
* Age \> 70
* Treatment with palliative intent (including those with tumor extent mandating the use of AP opposing facio-cervical field technique)
* Prior malignancy except adequately treated basal cell or squamous cell skin cancer, in-situ cervical cancer, or other cancer for which the patient has been disease-free for five years.
* Pregnancy or lactation (consider pregnancy test in women of child-bearing age and emphasize effective contraception during the treatment period).
* History of previous RT (except for non-melanomatous skin cancers outside intended RT treatment volume).
* Prior chemotherapy or surgery (except diagnostic) to primary tumor or nodes.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00577057
Study Brief:
Protocol Section:
NCT00577057